Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

524 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

NCT04890613

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +26 more
Locations
  • University of California, Los Angeles Santa Monica, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Hospital Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +31 more
Locations
  • Macquarie University Health Ryde, New South Wales, Australia
  • The Kinghorn Cancer Center Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Recruiting

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

NCT04145622

Conditions
Advanced Solid Tumor, Malignant Solid Tumor, Neoplasms
Locations
  • Cedars-Sinai Medical Center- Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

NCT05329103

Conditions
Advanced Solid Tumor
Locations
  • HonorHealth Research Institiute Scottsdale, Arizona, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Abramson Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions